u.s. fda begins inspection at aurobindo pharma's jadcheria unit: sources | trading hour | cnbc-tv18
Published 1 year ago • 1.9K plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
1:37
aurobindo pharma surges as eugia steriles' andhra facility gets first us fda approval for injectable
-
1:32
aurobindo pharma's key unit inspected by us fda with zero observations
-
2:31
u.s. fda issues 10 observations to aurobindo pharma under form 483 | halftime report | cnbc-tv18
-
1:43
usfda inspection of eugia-iii unit of aurobindo pharma underway, stock under pressure | cnbc tv18
-
2:11
us fda to begin inspections at gland pharma's injectables plant on jun 15: source | cnbc tv18
-
7:10
bajaj housing, swiggy, lg, hyundai: ipos drive indian stock market boom | vantage with palki sharma
-
5:27
what are the key stocks & sectors in focus today? | cnbc tv18
-
4:23
ace investor rakesh jhunjhunwala quizzes n govindarajan of aurobindo pharma
-
2:35
aurobindo pharma under pressure after us fda issues warning letter for eugia unit iii | cnbc tv18
-
1:54
aurobindo pharma's arm apl healthcare units get vai status from u.s. fda | halftime report
-
2:05
u.s fda commences inspections of lupin and aurobindo pharma's facilities | halftime report
-
12:01
us, asia mixed ahead of fed's monetary policy decision; flat start on d-street today? | cnbc tv18
-
1:16
aurobindo pharma temporarily halts production at eugia’s unit-iii after 9 us fda observations
-
1:44
us fda issues observations on aurobindo pharma and ajanta pharma | business lunch | cnbc-tv18
-
0:50
#shorts | usfda inspects pharma space
-
17:15
aurobindo pharma: unit 4 | us fda blow; issues 9 observations to unit 4 | cnbc tv18
-
8:09
aurobindo pharma's unit-iv plant gets clearance from us fda | midcap radar
-
3:48
aurobindo pharma gets establishment inspection report for unit-iv
-
3:02
aurobindo pharma under pressure after us fda warning letter, divi's lab rises on positive news
-
1:30
what should you expect from aurobindo pharma this q1?
-
20:12
aurobindo pharma makes coluntary recall of multiple injectables manufactured for us | trading hours
-
1:15
aurobindo pharma gets 3 us fda approvals overnight